signaling pathways activated in mpns: targeting the dusp6-rsk1 pathway
Published 1 year ago • 92 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:47
signaling pathways involved in drug resistance in mpns
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
1:59
the role of inflammatory signaling pathways in lower-risk mds
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:41
an overview of the mds diagnosis pathway
-
1:51
checkpoint inhibition in the treatment of mpns
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
9:25
mgus diagnosis: a step-by-step approach
-
5:31
aziz nazha, md: how do tp53 mutation characteristics affect mds outcomes?
-
1:33
social media: creating a link between patients and researchers
-
1:02
maintenance therapy following treatment for amyloidosis
-
1:19
what's on the horizon for the treatment of mpns?
-
1:52
the future is bright for hematological oncology: promising areas for 2018 and beyond
-
2:20
ultra high-risk myeloma
-
1:52
the importance of symptom management in mpns
-
0:45
difference between quality of life & patient-reported outcomes
-
2:09
heart transplantation in attr amyloidosis
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
2:00
an update on the genomic landscape of mm
-
0:47
overview of the phase iii enhance trial schema
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all